The medical management of primary hyperparathyroidism.
Primary hyperparathyroidism has become a relatively common endocrine disorder. Greater recognition of this disease has led to earlier detection. Consequently, primary hyperparathyroidism is now characterized frequently by asymptomatic mild hypercalcemia rather than by the more classical presentation with bone or renal involvement. Patients who have hypercalcemia and signs or symptoms should undergo neck surgery and removal of the abnormal parathyroid tissue. For the growing population of asymptomatic patients, however, indications for surgery are not as clear. The natural history of primary hyperparathyroidism is variable, and predicting who will develop complications of this disorder is not possible. Alternatives to surgery are careful and regular observation combined with various general and specific approaches currently receiving attention. Available information on the medical management of asymptomatic, mild primary hyperparathyroidism is summarized.
D002116:Calcitonin / Q000627:therapeutic use; D002136:Calcium, Dietary / Q000008:administration & dosage; D002927:Cimetidine / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000628:therapy; D006961:Hyperparathyroidism / Q000628:therapy*; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors; D010710:Phosphates / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use
D002136:Calcium, Dietary; D004164:Diphosphonates; D004967:Estrogens; D010281:Parathyroid Hormone; D010710:Phosphates; D002927:Cimetidine; D002116:Calcitonin; D011433:Propranolol